I have comprehensive information from multiple authoritative sources. Let me now compile a thorough response.
Viral Pneumonia
A comprehensive overview drawn from Murray & Nadel's Respiratory Medicine, Robbins Pathologic Basis of Disease, Rosen's Emergency Medicine, and Goldman-Cecil Medicine.
Definition & Overview
Viral pneumonia is an infection of the lower respiratory tract parenchyma caused by viruses, leading to inflammation of the alveoli and surrounding interstitium. It can range from mild self-limited disease to life-threatening illness requiring ICU-level care.
Common Causative Agents
The following viruses are the principal causes of community-acquired viral pneumonia:
| Virus | Notes |
|---|
| Influenza A & B | Leading cause in adults; pandemic potential via antigenic shift |
| Respiratory Syncytial Virus (RSV) | Most common in infants and young children |
| Human Metapneumovirus | Clinically similar to RSV |
| SARS-CoV-2 | COVID-19; major cause since 2020 |
| Adenovirus | Can cause severe pneumonia in military recruits |
| Rhinovirus | Usually mild, but can progress in immunocompromised |
| Varicella-Zoster Virus | Pneumonitis especially severe in pregnant women (35% mortality historically) |
| Rubeola (Measles) | Severe pneumonia in malnourished, immunosuppressed patients |
Risk factors for progression to severe lung disease include extremes of age, malnutrition, alcoholism, and underlying debilitating illnesses. - Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 663
Pathogenesis
From Robbins Pathologic Basis of Disease, the general mechanisms of viral pneumonia are well understood:
- Viral attachment and entry: Viruses attach to and enter respiratory epithelial cells (e.g., influenza hemagglutinin binds sialic acid residues on cell-surface polysaccharides, followed by endosomal fusion).
- Cytopathic injury: Viral replication inhibits host cell mRNA translation and activates caspases, causing apoptosis of pneumocytes. Sodium channel inhibition causes fluid shifts leading to alveolar flooding.
- Inflammatory cascade: Dying cells release danger signals activating resident macrophages; inflammatory mediators (chemokines, cytokines) recruit neutrophils into the interstitium within 1-2 days.
- Impaired host defenses: Mucociliary clearance is disrupted, predisposing to bacterial superinfection (most commonly S. aureus, which can be life-threatening).
- Innate immune response: Type I interferon production upregulates MX1 gene (encodes a GTPase that interferes with viral replication); NK cells and cytotoxic T cells kill infected cells.
Antigenic concepts for influenza:
- Antigenic drift - spontaneous point mutations in hemagglutinin/neuraminidase genes; causes annual epidemics
- Antigenic shift - reassortment of entire gene segments from animal influenza strains (swine/avian); causes pandemics (e.g., 1918, 2009 H1N1)
Clinical Features
Adults
- Gradual onset with cough, fever, myalgia, headache, malaise
- May have rhinorrhea and pharyngitis
- Tachypnea, dyspnea, pleuritic chest pain in more severe disease
- Crackles on auscultation; wheezing possible
Children (Rosen's Emergency Medicine)
- More common in winter season
- Gradual onset with cough, congestion, and low-grade fever
- Tachypnea may be the only physical finding in mild cases
- Retractions, rales, and wheezing are common
- Severe: grunting, cyanosis, lethargy, dehydration, apnea (especially in infants < 3 months)
Radiology
Chest X-ray in viral pneumonia typically shows:
- Hyperinflation
- Peribronchial thickening (cuffing)
- Diffuse bilateral interstitial infiltrates
- Patchy areas of consolidation (lobular atelectasis)
Lobar consolidation and pleural effusions can occur but are more characteristic of bacterial pneumonia.
Portable chest X-ray showing bilateral interstitial pattern characteristic of viral pneumonia - Rosen's Emergency Medicine
Special Populations
Pregnancy (Murray & Nadel)
| Virus | Key Points |
|---|
| Influenza A/B | Significantly higher mortality than general population; 35% ICU admission and 7% death in 2009 H1N1 pandemic |
| Varicella | 35% mortality historically in pregnant women; treat with IV acyclovir |
| SARS-CoV-2 | Higher ICU/ventilation rates; risk factors include obesity, asthma, hypertension, age >35; use dexamethasone with caution (higher dose needed if preterm for fetal lung maturity) |
Vaccines: Inactivated influenza vaccine recommended in any trimester. Live attenuated vaccines (varicella, LAIV) are contraindicated in pregnancy.
Diagnosis
- Clinical: Winter presentation + fever + cough + interstitial infiltrates strongly suggests viral etiology
- Children generally do not require CXR or viral testing if clinical picture is clear
- Rapid antigen tests / PCR: for influenza, RSV, SARS-CoV-2
- Serology: Useful for retrospective diagnosis
- Lab findings: leukopenia or normal WBC (in contrast to leukocytosis in bacterial pneumonia); lymphopenia common with SARS-CoV-2
Management
Outpatient (Goldman-Cecil Medicine)
| Suspected Virus | Treatment |
|---|
| SARS-CoV-2 | Per COVID-19 protocols (nirmatrelvir/ritonavir if eligible) |
| Influenza | Oseltamivir 75 mg twice daily × 5 days |
| Other viral | Supportive care; treat for possible bacterial co-infection |
Inpatient (Goldman-Cecil Medicine)
- Influenza: Oseltamivir 75 mg twice daily × 5 days PLUS cover for bacterial co-infection (beta-lactam ± macrolide or respiratory fluoroquinolone)
- Other viral pneumonias: Treat as bacterial co-infection empirically (beta-lactam + macrolide or respiratory quinolone)
- SARS-CoV-2 severe: Dexamethasone, remdesivir; consider baricitinib or tocilizumab for cytokine storm
Supportive care
- Supplemental oxygen, escalating to high-flow nasal cannula or mechanical ventilation if needed
- Hydration
- Antipyretics/analgesics
- Bronchodilators if wheezing
Complications
- Bacterial superinfection (most common and serious - especially S. aureus, S. pneumoniae)
- ARDS (in severe influenza, COVID-19)
- Dehydration (especially in children)
- Bronchiolitis obliterans (rare, post-viral)
- Apnea (in infants)
- Secondary bacterial pneumonia (particularly S. aureus co-infection in influenza)
- Myocarditis (influenza, adenovirus)
Key Distinguishing Features: Viral vs. Bacterial Pneumonia
| Feature | Viral | Bacterial |
|---|
| Onset | Gradual | Abrupt |
| Fever | Low-grade | High-grade, rigors |
| WBC | Normal or low; lymphopenia | Leukocytosis with left shift |
| CXR | Bilateral interstitial infiltrates | Lobar consolidation |
| Sputum | Scant, watery | Purulent |
| Pleural effusion | Uncommon | More common |
| Procalcitonin | Low | Elevated |
Sources:
- Murray & Nadel's Textbook of Respiratory Medicine (Viral Pneumonia in Pregnancy chapter)
- Robbins, Cotran & Kumar Pathologic Basis of Disease, pp. 663-664
- Rosen's Emergency Medicine, p. 3192 (Pediatric Viral Pneumonia)
- Goldman-Cecil Medicine International Edition, Chapter 85 (Outpatient & Inpatient Management Tables)